TCL Archive NCI Internal Debate Ends With Move of Biometry Branch, Including SEER, From DCCP To DRCCA September 23, 1983
TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive Van Brings Free Brain MRIs To Capitol Hill; Experts See Enormous Potential For Harm May 8, 2009
TCL Archive U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention April 29, 2005
TCL Archive Fallout Over PSA Guidance Continues—Specialty Groups Dissent, Congress Attacks July 20, 2012
